Charles Calderaro III

Prior to joining Shoreline, Mr. Calderaro served as Global Head of Technical Operations for Kite Pharma, a pioneer in cell therapy development, where he was responsible for leading all aspects of Kite’s technical operations, including process development, CMC regulatory, manufacturing, quality, supply chain, engineering, end-to-end optimization of commercial and pipeline products.

While at Kite, Mr. Calderaro oversaw manufacturing of CAR-T cell therapy products at an unparalleled commercial scale. Prior to Kite, Mr. Calderaro was Senior Vice President, Global Manufacturing at BioMarin Pharmaceutical, where he was responsible for the strategic oversight and leadership of a diverse international manufacturing network, which utilizes small molecule, oligonucleotide, biotechnology, and gene therapy technologies to deliver an innovative portfolio of clinical and commercial products to patients. Before that, he spent fourteen years at Genentech in roles of increasing responsibility in product management, engineering, and manufacturing.

Early in his career, Mr. Calderaro spent time at Alcon, a division of Novartis, and operations. Mr. Calderaro received a Bachelor’s degree, Electrical Engineering from the University of Notre Dame, a Master’s Degree, Nuclear Engineering from the US Naval Nuclear Power School and a Masters of Business Administration from Texan Christian University.